TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 10 | 56 | 94 | 178 | 498 | 140 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/14/21 17:30 | 1/12/21 | CGEM | Cullinan Management, Inc. | Health | BioPrd | Biological Products, (No Diag | Jovan-Embiricos Morana | MA | DT | P.d | 4,200 | 21.00 | 0 | 200 | 999% | 217 | I | ||||||||||||||||
8/6/20 06:06 | 8/3/20 | ALVR | Allovir, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jovan-Embiricos Morana | MA | DT | P.d | 49,300 | 17.00 | 0 | 2,900 | 2,830 | I | ||||||||||||||||
2/21/19 17:01 | 2/19/19 | TCRR | Tcr2 Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Jovan-Embiricos Morana | MA | DT | P.d | 10,000 | 15.00 | 0 | 667 | 537 | I | ||||||||||||||||
6/13/14 10:13 | 6/11/14 | RDUS | Radius Health, Inc. | DE | Financ | AcqCo | Blank Checks | Jovan-Embiricos Morana | MA | DT | P.d | 4,700 | 8.00 | 3 | 588 | 38 | 2,145 | I | 0 | 3 | 10 | 56 | 94 | 178 | 498 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |